FDA Clearance Tracker · P950014-S020
PROSTATRON
Last checked: Nov 20, 2026Latest source record: Apr 13, 2000 (this decision)Source: openFDAMethods & limitations
Decided
Apr 13, 2000
Approved
Time to decision
139 days
Received Nov 26, 1999. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P950014-S020
- Device name
- PROSTATRON
- Applicant
- Urologix, Inc.
- Applicant location
- Plymouth, MN
- Received
- Nov 26, 1999
- Decided
- Apr 13, 2000
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P950014
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
Approval for changes to the Prostatron software program to include the 30-Minute TUMT treatment protocol.
Source documents
Other decisions for Urologix, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K142248 · Decided Feb 20, 2015 · 190 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.